- Home
- MRKR vs FBIOP Comparison
MRKR vs FBIOP Comparison
Compare MRKR & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- FBIOP
- Stock Information
- Founded
- MRKR N/A
- FBIOP N/A
- Country
- MRKR United States
- FBIOP United States
- Employees
- MRKR N/A
- FBIOP 186
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- MRKR Health Care
- FBIOP Health Care
- Exchange
- MRKR Nasdaq
- FBIOP Nasdaq
- Market Cap
- MRKR N/A
- FBIOP N/A
- IPO Year
- MRKR N/A
- FBIOP N/A
- Fundamental
- Price
- MRKR $1.23
- FBIOP $6.00
- Analyst Decision
- MRKR Strong Buy
- FBIOP
- Analyst Count
- MRKR 2
- FBIOP 0
- Target Price
- MRKR $13.50
- FBIOP N/A
- AVG Volume (30 Days)
- MRKR 254.6K
- FBIOP N/A
- Earning Date
- MRKR 03-31-2025
- FBIOP N/A
- Dividend Yield
- MRKR N/A
- FBIOP N/A
- EPS Growth
- MRKR N/A
- FBIOP N/A
- EPS
- MRKR N/A
- FBIOP N/A
- Revenue
- MRKR $5,395,849.00
- FBIOP N/A
- Revenue This Year
- MRKR $156.32
- FBIOP N/A
- Revenue Next Year
- MRKR N/A
- FBIOP N/A
- P/E Ratio
- MRKR N/A
- FBIOP N/A
- Revenue Growth
- MRKR 79.04
- FBIOP N/A
- 52 Week Low
- MRKR $1.13
- FBIOP N/A
- 52 Week High
- MRKR $5.99
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- MRKR 41.00
- FBIOP 40.48
- Support Level
- MRKR $1.15
- FBIOP $6.26
- Resistance Level
- MRKR $1.39
- FBIOP $6.74
- Average True Range (ATR)
- MRKR 0.11
- FBIOP 0.26
- MACD
- MRKR 0.02
- FBIOP -0.02
- Stochastic Oscillator
- MRKR 32.26
- FBIOP 10.30
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.